<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20240528061935N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-06-01</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) with and without Physical Activity on Depressive Symptoms, Brain Map , Physical Condition and Sleep Quality of Depressed Patients</public_title>
      <acronym></acronym>
      <scientific_title>Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) with and without Physical Activity on Depressive Symptoms, Brain Map , Physical Condition and Sleep Quality of Depressed Patients</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2024-05-01</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/77076</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Patients are randomly assigned to the intervention and control groups using the random block method. Then random replacement is done by lottery method (one number will be assigned to each of the sampled people). We write down the numbers on paper, then fold them and put them in a container. We mix and stir the papers completely. Then we take out the papers one by one and place one number in the first group and one number in the second group, respectively. Then random application will be done. In this way, one group is known as "control group" and the other group is known as "intervention group". In this way, to randomly determine the "control group" and the "intervention group", we put the set of each group in two separate envelopes and put them in a container. Then we randomly take one envelope out of the container and assign it to the "intervention group" and the other envelope to the "control group", Blinding description: Due to the fact that the patients do not know about the group assignment, a blind study is performed.</study_design>
      <phase>2-3</phase>
      <hc_freetext>Major Depressive Disorder.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: They will receive the rTMS protocol in addition to the usual treatment. The research was conducted in such a way that the subjects will be evaluated by the Beck depression test one week before rTMS. Then they will be treated with rTMS for 25 sessions (regularly on 5 days of the week) and for 20 minutes of magnetic stimulation in the dorsolateral area of ​​the prefrontal cortex of the left hemisphere (with the opinion of the attending physician). During the study, subjects will take their medicines without any changes. Checking the dose and the amount of medication and changing the drugs during the treatment period, if it occurs, will be excluded from the study. Intervention 2: Control group: rTMS will be received off.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data can be shared after de-identification.

When:
Data can be made available 6 months after results are published.

To whom:
Researchers in scientific and academic centers can access the data.

Conditions:
The data can be used in meta-analyses if the names of the main researchers are mentioned.

Where to obtain:
If you need data, write to firoozefadaee1@gmail.com.

How to obtain:
After receiving the request and its review by the main researcher, the data will be sent to the applicant along with a letter of commitment stating that the data will not be published without the name of the main researcher within one month.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Firouze Fadaei Goke</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ali Mahmoudi Street, Qamiyeh Township</address>
        <city>Eslamshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3315865451</zip>
        <telephone>+98 21 5649 3166</telephone>
        <email>firoozefadaee1@gmail.com</email>
        <affiliation>Islamic Azad University, Semnan branch</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Firouze Fadaei Goke</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ali Mahmoudi Street, Qamiyeh Township</address>
        <city>Eslamshahr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3315865451</zip>
        <telephone>+98 21 5649 3166</telephone>
        <email>firoozefadaee1@gmail.com</email>
        <affiliation>Islamic Azad University, Semnan branch</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Minimum literacy to read and write
Completing the patients' consent form to participate in the experiment
Getting a score above 20 in the Beck depression Inventory
No history of special diseases and mental illnesses
Not taking psychotropic drugs
No drug addiction
No history of seizures and epilepsy
Have a minimum age of 18 and a maximum age of 65 years</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Unwillingness to continue cooperation
Failure to complete research questionnaires or filling them incompletely
Having intracranial implants (shunts, stimulators, electrodes) and any other metal object near the head</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>F32</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Major depressive disorder, single episode</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Drugs</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: They will receive the rTMS protocol in addition to the usual treatment. The research was conducted in such a way that the subjects will be evaluated by the Beck depression test one week before rTMS. Then they will be treated with rTMS for 25 sessions (regularly on 5 days of the week) and for 20 minutes of magnetic stimulation in the dorsolateral area of ​​the prefrontal cortex of the left hemisphere (with the opinion of the attending physician). During the study, subjects will take their medicines without any changes. Checking the dose and the amount of medication and changing the drugs during the treatment period, if it occurs, will be excluded from the study.</i_keyword>
      <i_keyword>Control group: rTMS will be received off.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Depression. Timepoint: Before and after 25 sessions of intervention. Method of measurement: Beck depression questionnaire is used to check depression.</prim_outcome>
      <prim_outcome>Quantitative electroencephalography. Timepoint: Before and after 25 sessions of intervention. Method of measurement: Quantitative electroencephalography measurement scale.</prim_outcome>
      <prim_outcome>Physical Condition. Timepoint: Before and after 25 sessions of intervention. Method of measurement: Lindenberg Physical Status Improvement Questionnaire.</prim_outcome>
      <prim_outcome>Sleep Quality. Timepoint: Before and after 25 sessions of intervention. Method of measurement: Pittsburgh Sleep Quality Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>CD3 and CD4 levels. Timepoint: In the intervals before and immediately after receiving repetitive brain magnetic stimulation (rTMS) treatment. Method of measurement: Routine blood sample Test for CD3-CD4 level count.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University, Semnan Branch</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-04-30</approval_date>
        <contact_name>Ethics Committee of Semnan Azad University</contact_name>
        <contact_address>Islamic Azad University, University Town, Semnan, Iran Semnan Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
